Devonian Health Group Updates Its Planned NYSE Listing

For a small-cap company that has spent years trading on a Canadian venture exchange and the US over-the-counter market, the move to a national exchange is often the moment a story changes. On Friday, Oct. 16, 2026, Devonian Health Group Inc. of Quebec City put out a status update on exactly that step: its proposed NYSE listing on the NYSE American, tied to an initial public offering in the United States.

Key takeaways

• Devonian, currently quoted on the TSX Venture Exchange under GSD and on the OTCQB under DVHGF, issued an update on Oct. 16 on its planned NYSE American listing.
• The listing is proposed in connection with a US initial public offering, which the company refers to as the “Offering.”
• A move from the OTCQB to a national exchange typically changes a company’s disclosure, governance and investor-access profile.
• Two other companies, Hawkeye Digital (HWKE) and Private Bancorp of America (PBAM), filed 8-Ks the same day that surfaced in searches for the term “uplisting.”

What Devonian announced

According to the company’s release, distributed by PR Newswire, Devonian is giving an update on its proposed listing on the NYSE American. The listing is linked to a US public offering of its shares. The company identifies itself by its two current quotations: the TSXV ticker GSD and the OTCQB ticker DVHGF.

That dual-venue footprint is the key to understanding the filing. The TSXV is Canada’s venue for early-stage and smaller issuers. The OTCQB is a US over-the-counter marketplace. Neither is a national securities exchange. A NYSE American listing would give the company a primary US exchange presence for the first time, alongside its existing Canadian listing.

Why the structure matters

Pairing an exchange listing with an offering is the conventional route for a company that wants to raise capital while it gains a new trading venue. It differs from a direct listing, in which shares are simply admitted to trade without a new capital raise. Here, the proposed listing is expressly connected to a primary offering, so the exchange approval and the offering’s completion are linked steps.

For existing shareholders, that link is the main thing to follow. A listing tied to an offering generally depends on the offering being priced and closed, and the company’s own disclosures are where the terms will appear. The update released Friday is the type of notice that precedes those milestones, though details on timing and terms should be read in the full release and any related regulatory filings.

A NYSE American listing tied to a US offering is less a single event than a chain of approvals, pricing and closing, and each link is disclosed separately.

Who is affected

The most direct audience is Devonian’s current holders on the TSXV and OTCQB, whose shares would sit alongside a new US listing if the plan is completed. Prospective US investors, who have so far had access through the OTCQB, would see the company move into the national exchange system and its rules.

Peers matter too. Cross-border issuers from Canada have long used US exchanges to widen their investor base, and each completed deal is a data point for others weighing the cost and obligations of a US listing against staying on a home-market venue.

Other uplisting filings the same day

Searches of SEC filings for the word “uplisting” on Oct. 16 returned Form 8-Ks from Hawkeye Digital, Inc. (HWKE) and Private Bancorp of America, Inc. (PBAM). A keyword match alone does not establish what either company disclosed or whether either has applied to a national exchange, so readers should consult the filings directly. They are a reminder that movement from over-the-counter markets to exchanges remains a steady feature of the small-cap landscape.

What to watch next

• Whether Devonian announces the pricing and closing of its US offering.
• Confirmation from NYSE American of approval to list, and the date trading would begin.
• Any change to the company’s TSXV and OTCQB quotations once a US listing takes effect.
• Further regulatory filings that spell out the offering’s size and terms.

Until those pieces arrive, Friday’s update is best read as a progress report rather than a completed listing.